aristolochic acid i has been researched along with Leukemia in 2 studies
aristolochic acid I: phospholipase A inhibitor
aristolochic acid A : An aristolochic acid that is phenanthrene-1-carboxylic acid that is substituted by a methylenedioxy group at the 3,4 positions, by a methoxy group at position 8, and by a nitro group at position 10. It is the most abundant of the aristolochic acids and is found in almost all Aristolochia (birthworts or pipevines) species. It has been tried in a number of treatments for inflammatory disorders, mainly in Chinese and folk medicine. However, there is concern over their use as aristolochic acid is both carcinogenic and nephrotoxic.
Leukemia: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Goun, E | 1 |
Cunningham, G | 1 |
Solodnikov, S | 1 |
Krasnykch, O | 1 |
Miles, H | 1 |
Tilz, GP | 1 |
Lanzer, G | 1 |
2 other studies available for aristolochic acid i and Leukemia
Article | Year |
---|---|
Antithrombin activity of some constituents from Origanum vulgare.
Topics: Antineoplastic Agents; Antithrombins; Aristolochic Acids; Leukemia; Molecular Structure; Origanum; R | 2002 |
[Immunotherapy II: clinical investigations for the induction and activity of interferon (author's transl)].
Topics: Aristolochic Acids; Dioxolanes; Humans; Inflammation; Interferons; Leukemia; Neoplasms; Phenanthrene | 1980 |